Financial Reports Latest Updates Industry Maps Economic Calendar

LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Annual Reports

Q: Where can I read LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

LIFECORE BIOMEDICAL, INC. \DE\ is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 05/25
SEC CIK： 1005286 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$34.2M	$8.7M	+294.3%
Operating income	$2.6M	$-590,000	+535.1%
Net income	$-6.2M	$-2.9M	-115.0%
EPS (diluted)	$-0.19	$-0.09	-111.1%

Company guidance
	Period	Range
Adjusted EBITDA	—	$120M – $125M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 34.2 mn Net income -6.16 mn

Periods follow the company’s fiscal year (Apple ends in September, Walmart in January), so they differ from calendar quarters.

Show table：Income statement

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
Revenue	238	65.0	70.2	73.5	68.1	73.3	81.6	80.1	82.6	102	115	118	107	109	120	126	121	134	133	139	134	135	140	130	135	109	110	129	121	116	122	145	141	125	125	156	153	139	143	153	156	136	131	138	140	129	129	53.1	47.6	43.4	38.8	27.6	31.1	24.5	30.1	35.7	37.9	24.7	32.6	5.69	35.1	36.4	8.66	31.1	66.9	23.2	34.2
Gross profit	33.8	11.8	11.9	12.5	10.6	11.3	13.0	13.2	14.7	13.8	18.5	17.5	13.0	12.5	13.7	20.2	16.1	14.2	15.7	16.9	18.7	18.0	17.3	12.9	22.8	21.1	18.9	23.4	19.7	19.3	15.8	20.1	24.8	16.3	16.6	21.2	26.2	15.3	15.5	20.1	24.1	16.4	20.6	19.7	24.8	17.5	13.0	13.9	12.1	5.82	7.11	5.98	7.78	2.73	9.96	11.9	17.3	5.39	11.1	-0.14	9.85	14.0	3.14	7.79	20.6	4.46	12.1
Operating income	7.98	3.93	3.53	3.75	-3.17	2.87	4.21	4.04	3.46	3.00	11.1	6.66	4.11	1.98	3.18	9.73	5.31	3.53	3.89	4.83	6.20	3.94	2.81	-33.6	7.09	5.47	3.26	4.33	2.44	2.52	-0.55	3.21	8.41	-0.45	-0.61	2.63	3.90	-4.38	-6.04	-15.0	-13.1	-12.5	-1.47	-0.79	1.23	-3.81	-37.0	-3.75	-38.9	-8.16	-7.91	-9.70	-1.23	-8.61	-1.48	-0.89	2.15	-11.6	-1.96	-5.70	-9.03	5.33	-0.59	-3.07	-0.14	-4.67	2.57
Net income	3.98	2.30	2.06	2.30	-2.74	1.81	3.34	4.76	2.78	2.54	8.91	4.79	4.52	4.75	3.45	6.40	4.54	2.35	3.22	3.77	4.20	2.95	1.87	-21.2	4.73	3.31	1.33	3.50	2.45	2.15	0.49	16.1	6.11	0.19	-0.58	1.07	-0.26	-4.78	-6.74	-11.5	-15.2	-11.0	-13.3	-5.50	-2.87	-9.48	-38.4	-12.8	-36.7	-12.1	-12.4	-40.2	-35.6	-10.8	14.2	15.6	-7.08	-16.2	-6.57	-7.84	-14.8	-1.15	-2.86	-9.99	-15.1	-15.0	-6.16

Balance sheet

Quarterly · In mn (USD)

Total assets 230 mn Total liabilities 213 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
Current assets	—	—	—	—	85.6	88.0	87.2	86.1	81.2	70.1	77.2	82.0	85.7	77.7	85.5	88.9	90.9	89.3	94.9	92.5	93.2	87.3	95.2	83.9	86.5	87.8	84.5	86.6	81.3	88.5	96.0	94.5	97.1	88.3	92.5	114	133	131	140	149	157	147	154	163	148	142	155	132	124	117	127	88.4	93.9	82.8	76.7	76.2	81.0	74.2	81.9	—	84.2	85.7	—	83.9	82.3	77.6	83.7
Total assets	—	—	—	—	206	209	209	212	278	268	278	283	291	291	302	307	314	326	341	340	346	343	361	329	343	344	341	346	359	367	379	386	405	403	412	502	519	546	560	550	541	506	499	510	503	446	422	326	295	286	279	236	254	246	246	246	254	247	255	—	238	239	—	235	232	226	230
Current liabilities	—	—	—	—	30.7	40.3	40.6	36.0	66.7	53.6	50.2	48.3	50.8	44.2	50.9	46.1	48.4	53.4	62.2	55.8	56.2	49.3	62.6	46.4	56.5	53.4	47.0	47.2	51.5	57.8	70.2	71.2	88.4	86.8	97.1	119	137	147	144	158	164	154	174	125	102	104	122	90.1	79.2	83.1	196	37.7	39.3	35.4	40.3	36.8	38.9	40.5	35.3	—	31.1	30.2	—	30.0	23.6	20.5	21.6
Total liabilities	—	—	—	—	68.6	67.5	67.0	61.9	126	113	110	108	111	105	112	107	109	118	130	125	126	119	134	122	131	127	122	122	130	136	147	136	152	150	158	232	249	281	301	302	310	285	290	305	300	252	266	182	187	189	205	163	218	219	203	187	200	207	196	—	190	192	—	198	198	205	213
Equity	—	—	—	—	136	140	141	148	150	153	166	173	179	184	189	198	203	206	210	214	218	222	225	205	211	215	218	223	227	230	231	249	253	253	254	270	270	265	259	248	231	221	209	205	203	194	156	144	108	96.9	74.2	34.2	-4.23	-13.6	1.42	17.7	11.3	-3.94	15.4	—	2.23	1.34	-0.86	-10.5	-14.2	-28.4	-34.1

Cash flow

Quarterly · In mn (USD)

Operating -2.19 mn Investing -0.51 mn Financing -0.85 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
Operating	7.48	4.38	2.07	12.4	2.04	4.36	-5.10	9.28	13.7	5.09	-2.70	11.1	7.76	4.54	-0.24	9.54	7.21	3.94	-0.59	10.0	12.8	-1.84	4.03	4.11	14.5	9.97	9.71	26.6	6.56	3.45	6.34	20.3	1.68	2.19	2.62	12.7	-1.43	-5.44	-9.48	10.6	-12.7	17.0	1.44	-7.86	4.42	0.83	-5.14	-20.1	0.04	-1.53	-2.95	-12.7	-0.27	-8.33	1.01	-1.53	8.64	-0.64	-6.11	—	1.20	5.35	—	1.76	7.33	4.70	-2.19
Investing	-42.8	-22.1	-22.6	-31.2	1.82	-5.55	6.40	-1.71	-43.2	-2.78	-2.45	-3.09	-2.09	-4.10	-2.04	-2.51	-4.69	-15.1	-10.0	-2.14	-7.16	-3.40	-12.6	-10.9	-13.5	-5.62	-8.91	-12.9	-16.0	-6.87	-11.5	-22.8	-15.0	-14.4	-3.95	-74.0	-4.42	-9.67	-5.97	-3.69	-4.57	0.23	5.25	-3.98	-12.4	38.3	-5.10	68.0	-19.4	0.21	-3.25	6.39	-8.16	-5.05	-3.98	-6.25	-2.64	-3.39	-2.47	—	1.54	-2.10	—	-1.74	6.30	-1.12	-0.51
Financing	19.7	-0.16	-1.82	-2.36	-2.40	0.3	-4.30	0.73	39.2	-14.4	-0.04	-2.91	-1.89	-5.26	-0.85	0.19	-1.26	5.44	7.07	2.84	-7.19	-1.79	7.41	9.05	0.75	-5.61	-2.52	-2.80	2.13	6.20	-2.11	0.6	8.61	10.7	1.49	61.6	5.21	16.0	15.1	-6.08	15.0	-17.0	-4.97	11.6	6.99	-39.0	9.88	-47.1	19.1	3.91	8.81	2.41	24.6	2.93	-2.45	7.64	-0.61	1.09	12.5	—	-6.78	-0.4	—	-1.39	-4.43	-0.26	-0.85
Cash at period end	27.8	9.90	5.45	6.68	8.14	7.24	4.24	12.5	22.2	10.1	4.86	9.94	13.7	8.90	5.77	13.0	14.2	8.53	4.97	15.7	14.1	7.10	5.98	8.21	9.89	8.63	2.57	12.7	5.41	8.19	4.37	7.65	2.90	1.36	1.51	1.72	1.08	1.99	1.59	2.61	0.36	0.59	2.49	2.25	1.30	1.45	1.09	1.85	1.64	4.22	6.83	2.95	19.1	8.64	3.22	3.07	8.46	5.52	9.46	—	5.42	8.27	20.2	18.9	17.5	20.8	17.2

Profitability

Quarterly · %

Gross margin 35.3% Operating margin 7.5% Net margin -18.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
Gross margin	14.2%	18.2%	16.9%	17.0%	15.5%	15.3%	15.9%	16.4%	17.8%	13.5%	16.1%	14.8%	12.2%	11.4%	11.4%	15.9%	13.3%	10.6%	11.8%	12.2%	13.9%	13.3%	12.3%	9.9%	16.8%	19.4%	17.2%	18.1%	16.2%	16.7%	12.9%	13.9%	17.6%	13.1%	13.3%	13.6%	17.2%	11.1%	10.9%	13.1%	15.4%	12.1%	15.8%	14.3%	17.7%	13.6%	10.0%	26.2%	25.4%	13.4%	18.3%	21.7%	25.0%	11.1%	33.0%	33.3%	45.6%	21.8%	34.0%	-2.5%	28.0%	38.4%	36.2%	25.0%	30.7%	19.2%	35.3%
Operating margin	3.4%	6.1%	5.0%	5.1%	-4.7%	3.9%	5.2%	5.0%	4.2%	2.9%	9.7%	5.7%	3.8%	1.8%	2.6%	7.7%	4.4%	2.6%	2.9%	3.5%	4.6%	2.9%	2.0%	-25.9%	5.2%	5.0%	3.0%	3.4%	2.0%	2.2%	-0.5%	2.2%	6.0%	-0.4%	-0.5%	1.7%	2.5%	-3.2%	-4.2%	-9.8%	-8.4%	-9.2%	-1.1%	-0.6%	0.9%	-3.0%	-28.6%	-7.1%	-81.8%	-18.8%	-20.4%	-35.1%	-4.0%	-35.1%	-4.9%	-2.5%	5.7%	-46.9%	-6.0%	-100.2%	-25.7%	14.6%	-6.8%	-9.9%	-0.2%	-20.1%	7.5%
Net margin	1.7%	3.5%	2.9%	3.1%	-4.0%	2.5%	4.1%	6.0%	3.4%	2.5%	7.8%	4.1%	4.2%	4.3%	2.9%	5.1%	3.8%	1.8%	2.4%	2.7%	3.1%	2.2%	1.3%	-16.3%	3.5%	3.0%	1.2%	2.7%	2.0%	1.9%	0.4%	11.1%	4.3%	0.1%	-0.5%	0.7%	-0.2%	-3.5%	-4.7%	-7.5%	-9.7%	-8.1%	-10.2%	-4.0%	-2.0%	-7.4%	-29.7%	-24.2%	-77.0%	-27.8%	-32.1%	-145.6%	-114.2%	-43.9%	47.2%	43.8%	-18.7%	-65.7%	-20.2%	-137.8%	-42.0%	-3.1%	-33.0%	-32.1%	-22.6%	-64.6%	-18.0%

Returns & leverage

Quarterly · %

ROE -364.9% ROA -20.1% Debt ratio 93.0%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
ROE	—	—	—	—	2.9%	2.5%	3.4%	4.8%	8.9%	9.2%	12.4%	11.8%	12.6%	13.6%	9.9%	10.3%	10.0%	8.6%	8.3%	6.7%	6.4%	6.6%	5.9%	-5.8%	-5.4%	-5.2%	-5.3%	6.0%	4.8%	4.2%	3.8%	9.0%	10.4%	9.5%	9.0%	2.6%	0.2%	-1.8%	-4.2%	-9.0%	-15.2%	-18.3%	-21.8%	-19.9%	-15.1%	-15.0%	-30.8%	-36.5%	-62.7%	-68.8%	-64.3%	-113.7%	-193.4%	-237.5%	-191.3%	-63.5%	339.1%	—	-169.0%	—	-670.5%	—	-364.9%	—	—	—	—
ROA	—	—	—	—	1.9%	1.6%	2.3%	3.4%	5.3%	5.6%	7.8%	7.7%	7.3%	8.2%	6.0%	6.5%	6.3%	5.4%	5.1%	4.3%	4.1%	4.2%	3.6%	-3.6%	-3.4%	-3.3%	-3.4%	3.8%	3.0%	2.6%	2.4%	5.8%	6.5%	5.9%	5.5%	1.5%	0.1%	-1.0%	-2.2%	-4.4%	-7.2%	-8.4%	-9.6%	-8.5%	-6.3%	-6.5%	-12.2%	-15.2%	-24.4%	-27.4%	-21.1%	-36.1%	-36.5%	-37.3%	-27.6%	-6.8%	4.7%	2.6%	-5.7%	—	-18.5%	-12.5%	—	-12.2%	-12.4%	-18.5%	-20.1%
Debt ratio	—	—	—	—	33.2%	32.3%	32.0%	29.3%	45.4%	42.1%	39.7%	38.3%	38.0%	36.2%	37.0%	34.9%	34.7%	36.3%	38.1%	36.7%	36.5%	34.6%	37.2%	37.1%	38.2%	36.9%	35.7%	35.3%	36.4%	37.0%	38.6%	35.2%	37.6%	37.1%	38.4%	46.2%	48.0%	51.5%	53.7%	55.0%	57.3%	56.3%	58.1%	59.9%	59.7%	56.5%	63.0%	55.8%	63.4%	66.1%	73.4%	69.2%	86.2%	89.2%	82.8%	75.9%	78.8%	84.0%	76.6%	—	80.0%	80.2%	—	84.4%	85.3%	90.8%	93.0%

EPS

Quarterly · US$

EPS US$-0.19

Show table：EPS

Item	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q2	2025Q3	2025Q4	2026Q1	2026Q1	2026Q2	2026Q3	2027Q1
EPS（US$）	0.15	0.09	0.08	0.09	-0.10	0.07	0.13	0.18	0.11	0.10	0.34	0.18	0.17	0.18	0.13	0.24	0.17	0.09	0.12	0.14	0.15	0.11	0.07	-0.78	0.17	0.12	0.05	0.13	0.09	0.08	0.02	0.58	0.22	0.01	-0.02	0.04	-0.01	-0.16	-0.23	-0.39	-0.52	-0.38	-0.45	-0.19	-0.10	-0.32	-1.30	-0.43	-1.88	-0.41	-0.42	-1.33	-1.32	-0.35	0.39	0.42	-0.20	-0.53	-0.25	-0.30	-0.47	-0.06	-0.09	-0.29	-0.45	-0.43	-0.19

Revenue & profit

Year-to-date · In mn (USD)

Revenue 34.2 mn Net income -6.16 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 230 mn Total liabilities 213 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -2.19 mn Investing -0.51 mn Financing -0.85 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 35.3% Operating margin 7.5% Net margin -18.0%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE -364.9% ROA -20.1% Debt ratio 93.0%

EPS

Year-to-date · US$

EPS US$-0.19

Revenue & profit

Annual · In mn (USD)

Revenue 135 mn Net income -46.5 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	277	318	442	477	539	541	470	524	558	590	544	359	141	128	135
Gross profit	46.7	52.1	62.8	62.6	65.4	71.0	83.2	80.0	80.4	75.0	81.5	56.5	26.7	41.9	40.1
Operating income	8.03	14.6	24.9	20.2	18.5	-19.8	15.5	13.6	5.48	-38.5	-13.5	-83.5	-27.0	-8.84	-22.9
Net income	3.92	12.7	20.8	19.1	13.5	-11.6	10.6	24.8	0.41	-38.2	-32.7	-97.4	-100	12.0	-46.5

Balance sheet

Annual · In mn (USD)

Total assets 239 mn Total liabilities 192 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	85.6	81.2	85.7	90.9	93.2	86.5	81.3	97.1	133	157	148	124	93.9	81.0	85.7
Total assets	206	278	291	314	346	343	359	405	519	541	503	295	254	254	239
Current liabilities	30.7	66.7	50.8	48.4	56.2	56.5	51.5	88.4	137	164	102	79.2	39.3	38.9	30.2
Total liabilities	68.6	126	111	109	126	131	130	152	249	310	300	187	218	200	192
Equity	136	150	179	203	218	211	227	253	270	231	203	108	-4.23	11.3	1.34

Cash flow

Annual · In mn (USD)

Operating -0.22 mn Investing -17.9 mn Financing 7.51 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	20.9	22.2	21.2	21.1	26.2	20.8	52.9	31.8	16.0	-17.0	15.0	-24.4	-17.4	-0.22	—
Investing	-74.2	-44.1	-10.4	-13.3	-34.4	-40.4	-43.4	-56.1	-96.8	-23.9	-10.9	81.8	-4.81	-17.9	—
Financing	-6.74	35.9	-19.3	-7.18	8.17	15.4	-8.80	13.3	79.0	40.0	-3.42	-57.0	39.7	7.51	—
Cash at period end	8.14	22.2	13.7	14.2	14.1	9.89	5.41	2.90	1.08	0.36	1.30	1.64	19.1	8.46	8.27

Profitability

Annual · %

Gross margin 29.8% Operating margin -17.1% Net margin -34.6%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	16.9%	16.4%	14.2%	13.1%	12.1%	13.1%	17.7%	15.3%	14.4%	12.7%	15.0%	15.7%	18.9%	32.6%	29.8%
Operating margin	2.9%	4.6%	5.6%	4.2%	3.4%	-3.7%	3.3%	2.6%	1.0%	-6.5%	-2.5%	-23.3%	-19.2%	-6.9%	-17.1%
Net margin	1.4%	4.0%	4.7%	4.0%	2.5%	-2.1%	2.3%	4.7%	0.1%	-6.5%	-6.0%	-27.1%	-71.2%	9.4%	-34.6%

Returns & leverage

Annual · %

ROE -736.0% ROA -18.9% Debt ratio 80.2%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	2.9%	8.9%	12.6%	10.0%	6.4%	-5.4%	4.8%	10.4%	0.2%	-15.2%	-15.1%	-62.7%	-193.4%	339.1%	-736.0%
ROA	1.9%	5.3%	7.3%	6.3%	4.1%	-3.4%	3.0%	6.5%	0.1%	-7.2%	-6.3%	-24.4%	-36.5%	4.7%	-18.9%
Debt ratio	33.2%	45.4%	38.0%	34.7%	36.5%	38.2%	36.4%	37.6%	48.0%	57.3%	59.7%	63.4%	86.2%	78.8%	80.2%

EPS

Annual · US$

EPS US$-1.61

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	0.16	0.49	0.79	0.72	0.50	-0.43	0.39	0.90	0.02	-1.30	-1.12	-3.93	-3.48	0.26	-1.61

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.